Antihyperlipemic and antihypertensive effects of <it>Spirulina maxima </it>in an open sample of mexican population: a preliminary report

<p>Abstract</p> <p>Background</p> <p><it>Spirulina maxima </it>is a filamentous cyanobacterium used as food supplement because of its high nutrient contents. It has been experimentally proven, <it>in vivo </it>and <it>in vitro </it>th...

Full description

Bibliographic Details
Main Authors: Juarez-Oropeza Marco A, Ferreira-Hermosillo Aldo, Torres-Duran Patricia V
Format: Article
Language:English
Published: BMC 2007-11-01
Series:Lipids in Health and Disease
Online Access:http://www.lipidworld.com/content/6/1/33
id doaj-631993e7ad1a453e870b3f5512f98362
record_format Article
spelling doaj-631993e7ad1a453e870b3f5512f983622020-11-25T00:18:34ZengBMCLipids in Health and Disease1476-511X2007-11-01613310.1186/1476-511X-6-33Antihyperlipemic and antihypertensive effects of <it>Spirulina maxima </it>in an open sample of mexican population: a preliminary reportJuarez-Oropeza Marco AFerreira-Hermosillo AldoTorres-Duran Patricia V<p>Abstract</p> <p>Background</p> <p><it>Spirulina maxima </it>is a filamentous cyanobacterium used as food supplement because of its high nutrient contents. It has been experimentally proven, <it>in vivo </it>and <it>in vitro </it>that posses several pharmacological properties. The purpose of this study was to evaluate the effects of <it>Spirulina maxima </it>orally supplied (4.5 g/day, for 6 weeks) to a sample of 36 subjects (16 men and 20 women, with ages between 18–65 years) on serum lipids, glucose, aminotransferases and on blood pressure. The volunteers did not modify their dietary habits or lifestyle during the whole experimental period. From each subject, a sample of blood was drawn in fasting state of 12 hours to determi the plasma concentrations of glucose, triacylglycerols (TAG), total cholesterol (TC), cholesterol associated to high density lipoprotein (HDL-C) and aspartate aminotransferase (AST). Anthropometric measurements including systolic (SYST-P) and diastolic (DIAST-P) blood pressure, height, weight and Body Mass Index (BMI) were also recorded.</p> <p>Results</p> <p>Comparing initial and final data, the results showed that there were no significant changes in the values of glucose and AST, but significant differences in TAG, TC, and HDL-C, were observed: TAG 233.7 ± 177.8 vs. 167.7 ± 100.7 mg/dL (p < 0.001), TC 181.7 ± 37.5 vs. 163.5 ± 34.4 mg/dL (p < 0.001), C-HDL 43.5 ± 14.4 vs. 50 ± 18.8 mg/dL (p < 0.01). The univariated analysis showed that the changes in the HDL-C and TC concentrations were dependent on TAG concentration (p = 0.247 and p = 0.108, respectively); nevertheless the calculated values for cholesterol associated to low density lipoprotein (LDL-C) were significantly reduced by the <it>Spirulina maxima </it>treatment but independently of the TAG changes. In addition, significant differences were found comparing initial and final SYST-P and DIAST-P blood pressure in both male and female: SYST-P male 121 ± 9 vs. 111 ± 8 mm Hg (p < 0.01), DIAST-P male 85 ± 6.5 vs. 77 ± 9 mm Hg (p < 0.01); SYST-P female 120 ± 9.5 vs. 109 ± 11 mm Hg (p < 0.002), DIAST-P female 85 ± 11 vs. 79 ± 7.5 mm Hg (p < 0.03).</p> <p>Conclusion</p> <p>The <it>Spirulina maxima </it>showed a hypolipemic effect, especially on the TAG and the LDL-C concentrations but indirectly on TC and HDL-C values. It also reduces systolic and diastolic blood pressure.</p> http://www.lipidworld.com/content/6/1/33
collection DOAJ
language English
format Article
sources DOAJ
author Juarez-Oropeza Marco A
Ferreira-Hermosillo Aldo
Torres-Duran Patricia V
spellingShingle Juarez-Oropeza Marco A
Ferreira-Hermosillo Aldo
Torres-Duran Patricia V
Antihyperlipemic and antihypertensive effects of <it>Spirulina maxima </it>in an open sample of mexican population: a preliminary report
Lipids in Health and Disease
author_facet Juarez-Oropeza Marco A
Ferreira-Hermosillo Aldo
Torres-Duran Patricia V
author_sort Juarez-Oropeza Marco A
title Antihyperlipemic and antihypertensive effects of <it>Spirulina maxima </it>in an open sample of mexican population: a preliminary report
title_short Antihyperlipemic and antihypertensive effects of <it>Spirulina maxima </it>in an open sample of mexican population: a preliminary report
title_full Antihyperlipemic and antihypertensive effects of <it>Spirulina maxima </it>in an open sample of mexican population: a preliminary report
title_fullStr Antihyperlipemic and antihypertensive effects of <it>Spirulina maxima </it>in an open sample of mexican population: a preliminary report
title_full_unstemmed Antihyperlipemic and antihypertensive effects of <it>Spirulina maxima </it>in an open sample of mexican population: a preliminary report
title_sort antihyperlipemic and antihypertensive effects of <it>spirulina maxima </it>in an open sample of mexican population: a preliminary report
publisher BMC
series Lipids in Health and Disease
issn 1476-511X
publishDate 2007-11-01
description <p>Abstract</p> <p>Background</p> <p><it>Spirulina maxima </it>is a filamentous cyanobacterium used as food supplement because of its high nutrient contents. It has been experimentally proven, <it>in vivo </it>and <it>in vitro </it>that posses several pharmacological properties. The purpose of this study was to evaluate the effects of <it>Spirulina maxima </it>orally supplied (4.5 g/day, for 6 weeks) to a sample of 36 subjects (16 men and 20 women, with ages between 18–65 years) on serum lipids, glucose, aminotransferases and on blood pressure. The volunteers did not modify their dietary habits or lifestyle during the whole experimental period. From each subject, a sample of blood was drawn in fasting state of 12 hours to determi the plasma concentrations of glucose, triacylglycerols (TAG), total cholesterol (TC), cholesterol associated to high density lipoprotein (HDL-C) and aspartate aminotransferase (AST). Anthropometric measurements including systolic (SYST-P) and diastolic (DIAST-P) blood pressure, height, weight and Body Mass Index (BMI) were also recorded.</p> <p>Results</p> <p>Comparing initial and final data, the results showed that there were no significant changes in the values of glucose and AST, but significant differences in TAG, TC, and HDL-C, were observed: TAG 233.7 ± 177.8 vs. 167.7 ± 100.7 mg/dL (p < 0.001), TC 181.7 ± 37.5 vs. 163.5 ± 34.4 mg/dL (p < 0.001), C-HDL 43.5 ± 14.4 vs. 50 ± 18.8 mg/dL (p < 0.01). The univariated analysis showed that the changes in the HDL-C and TC concentrations were dependent on TAG concentration (p = 0.247 and p = 0.108, respectively); nevertheless the calculated values for cholesterol associated to low density lipoprotein (LDL-C) were significantly reduced by the <it>Spirulina maxima </it>treatment but independently of the TAG changes. In addition, significant differences were found comparing initial and final SYST-P and DIAST-P blood pressure in both male and female: SYST-P male 121 ± 9 vs. 111 ± 8 mm Hg (p < 0.01), DIAST-P male 85 ± 6.5 vs. 77 ± 9 mm Hg (p < 0.01); SYST-P female 120 ± 9.5 vs. 109 ± 11 mm Hg (p < 0.002), DIAST-P female 85 ± 11 vs. 79 ± 7.5 mm Hg (p < 0.03).</p> <p>Conclusion</p> <p>The <it>Spirulina maxima </it>showed a hypolipemic effect, especially on the TAG and the LDL-C concentrations but indirectly on TC and HDL-C values. It also reduces systolic and diastolic blood pressure.</p>
url http://www.lipidworld.com/content/6/1/33
work_keys_str_mv AT juarezoropezamarcoa antihyperlipemicandantihypertensiveeffectsofitspirulinamaximaitinanopensampleofmexicanpopulationapreliminaryreport
AT ferreirahermosilloaldo antihyperlipemicandantihypertensiveeffectsofitspirulinamaximaitinanopensampleofmexicanpopulationapreliminaryreport
AT torresduranpatriciav antihyperlipemicandantihypertensiveeffectsofitspirulinamaximaitinanopensampleofmexicanpopulationapreliminaryreport
_version_ 1725375739694415872